A radiomics-based imaging tool to monitor tumor-lymphocyte infiltration and outcome in cancer patients treated by anti-PD-1/PD-L1
A radiomics and cellular technology, applied in the field of biomarkers, can solve the problem of low level of evidence
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0164] Example 1: Contrast-Enhanced Computed Tomography (CT) Imaging of Head and Neck Cancer
[0165] training group
[0166] Clinical and imaging data from the head and neck squamous cell carcinoma cohort provided by The Cancer Imaging Archive (http: / / www.cancerimagingarchive.net / ) (TCIA-HNSC) were used [35, 36]. Baseline contrast-enhanced computed tomography (CT) imaging with slice thickness equal to or less than 5 mm and acquired using a 120KVP was reviewed. After excluding patients with only postoperative imaging or artifacts at the tumor level, no gantry-tilt (for technical compatibility with our texture imaging software), and no available genomic data, 57 patients were included. patient.
[0167] The corresponding genomic data were obtained from the Cancer Genome Altas (TCGA) Portal (https: / / portal.gdc.cancer.gov / ), which included the use of Illumina HiSeq RNASeqV2 (Illumina, San Diego, California, USA ) and quantified 20,530 genes using the RPKM (Reads Per Kilobase M...
Embodiment 2
[0202] Example 2: Contrast-enhanced CT-based radiomics labeling of different solid tumors
[0203] Radiomics features were extracted from contrast-enhanced CT in 135 patients with advanced solid malignancies in the prospective trial MOSCATO. For each patient, RNA-seq data were used to quantify CD8 T cells. From 84 variables (78 radiomics features, 5 location variables, 1 technology variable), radiomics-based predictors of CD8 T cell expression were constructed using Elastic Net. The primary goal was to confirm the relationship of this predictor to gene expression in an independent cohort of 119 patients from The Cancer Genome Atlas (TCGA). Two separate cohorts of patients with solid tumors were used to assess this predictor: 100 patients were assumed to have tumors that were either immune primed (dense CD8 T cell infiltration) or immune desert (limited CD8 T cell infiltration) , to analyze the correlation with the immune phenotype, and 137 patients treated in a phase 1 trial...
PUM
Property | Measurement | Unit |
---|---|---|
thickness | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com